SCHEMBL19983789

SCHEMBL19983789

N#CC(C#N)=C1CCCCC12OCCCO2

nearest known ligand 0.34

Predicted protein targets (top 3)

geneUniProtsupporting neighboursconfidence
GPR35 Q9HC97 1/20 0.32
ALDH1A1 P00352 1/20 0.31
HSD17B10 Q99714 1/20 0.31

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL21319056 0.94 GPR35 (0.33) GPR35ALDH1A1HSD17B10
SCHEMBL19983784 0.68 ALDH1A1 (0.35) GPR35ALDH1A1HSD17B10
SCHEMBL15540440 0.67
SCHEMBL4051214 0.64 KRAS (0.39) GPR35ALDH1A1HSD17B10
SCHEMBL21319035 0.63 ALDH1A1 (0.32) ALDH1A1HSD17B10
SCHEMBL21319095 0.61 ALDH1A1 (0.30) ALDH1A1HSD17B10
SCHEMBL11486086 0.59 TSHR (0.36)
SCHEMBL19973082 0.59 ALDH1A1 (0.33) GPR35ALDH1A1HSD17B10
SCHEMBL940164 0.59 HTT (0.33)
SCHEMBL5508352 0.58 ALDH1A1 (0.60) GPR35ALDH1A1HSD17B10

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20190270700-A1 METHODS AND COMPOSITIONS FOR TERPENOID SYNTHESIS UNIV FLORIDA (US) 2019-09-05 US disclosed
WO-2018053322-A1 METHODS AND COMPOSITIONS FOR TERPENOID SYNTHESIS UNIVERSITY OF FLORIDA RESEARCH FOUNDATION, INC. (US) 2018-03-22 WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20190270700-A1 METHODS AND COMPOSITIONS FOR TERPENOID SYNTHESIS SQLE, GGPS1, LSS GPR35 3418/4885ALDH1A1 1353/4885HSD17B10 675/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.